Abstract:The inter-neuronal communication occurring in extensively branched neuronal cells is achieved primarily through the microtubule (MT)-mediated axonal transport system. This mechanistically regulated system delivers cargos (proteins, mRNAs and organelles such as mitochondria) back and forth from the soma to the synapse. Motor proteins like kinesins and dynein mechanistically regulate polarized anterograde (from the soma to the synapse) and retrograde (from the synapse to the soma) commute of the cargos, respectively. Proficient axonal transport of such cargos is achieved by altering the microtubule stability via post-translational modifications (PTMs) of α- and β-tubulin heterodimers, core components constructing the MTs. Occurring within the lumen of MTs, K40 acetylation of α-tubulin via α-tubulin acetyl transferase and its subsequent deacetylation by HDAC6 and SIRT2 are widely scrutinized PTMs that make the MTs highly flexible, which in turn promotes their lifespan. The movement of various motor proteins, including kinesin-1 (responsible for axonal mitochondrial commute), is enhanced by this PTM, and dyshomeostasis of neuronal MT acetylation has been observed in a variety of neurodegenerative conditions, including Alzheimer's disease and Parkinson's disease (PD). PD is the second most common neurodegenerative condition and is closely associated with impaired MT dynamics and deregulated tubulin acetylation levels. Although the relationship between status of MT acetylation and progression of PD pathogenesis has become a chicken-and-egg question, our review aims to provide insights into the MT-mediated axonal commute of mitochondria and dyshomeostasis of MT acetylation in PD. The enzymatic regulators of MT acetylation along with their synthetic modulators have also been briefly explored. Moving towards a tubulin-based therapy that enhances MT acetylation could serve as a disease-modifying treatment in neurological conditions that lack it.

Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes

Decoding the Role of Nuclear Sirtuins in Parkinson's Pathogenesis

The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations

Mitochondrial Sirtuins in Parkinson’s Disease

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

The role of sirtuin 1 in ageing and neurodegenerative disease: A molecular perspective

Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators

SIRT1 attenuates neuroinflammation by deacetylating HSPA4 in a mouse model of Parkinson's disease

The beneficial role of SIRT1 in preventive or therapeutic options of Neurodegenerative Diseases

Epigenetic Modifications in Parkinson's Disease: A Critical Review

SIRT1 Deacetylates TET2 and Promotes Its Ubiquitination Degradation to Achieve Neuroprotection Against Parkinson's Disease

Silent Information Regulator 1/Peroxisome Proliferator‐Activated Receptor‐γ Coactivator‐1α Axis: A Promising Target for Parkinson's and Alzheimer's Disease Therapies

Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease

Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics

Microtubule acetylation dyshomeostasis in Parkinson's disease

SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2

Therapeutic potential of Parkin and its regulation in Parkinson's disease

Therapeutic Implications and Regulations of Protein Post-translational Modifications in Parkinsons Disease

Interplay between α-synuclein and parkin genes: Insights of Parkinson's disease

Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease

Activation and inhibition of sirtuins: From bench to bedside